Player News
Carey Price's status remains uncertain following his PRP injection.
"You've got to give it time for the injection to have its intended effect, and then when he returns [to training], he'll have a progression of rehab and return to activity along the way," said Canadiens GM Kent Hughes. "We're always in the same position with him in terms of watching how his knee responds and is there a point or particular exercise as he ramps up that triggers the inflammation again and makes it difficult for him to be a full-time goalie. I don't know if I have that answer in terms of what the exact schedule would be for him [with respect to his offseason training]. From our perspective, whether he's ready to go in September or October or November is less concerning than getting kind of a more permanent resolution to the situation, which is: Is he capable of being a full-time goalie in the NHL or not? When we get that, then we have clarity." The team hopes that he will be on the ice for training camp
The uncertainty about Carey Price's situation influenced the Canadiens' decision to trade Shea Weber's contract.
Weber is unfortunately not expected to ever play in the NHL again and will consequently spend the final four seasons of his contract on the long-term injured reserve list. While they could have lived with his $7,857,143 cap hit on the LTIR in a vacuum, one thing Montreal didn't want to risk is the possibility that both Weber and Price, with his $10.5 million cap hit, were on the LTIR. Because Price's health is uncertain, Montreal traded Weber to avoid a situation where they entered the season carrying nearly $20 million on the LTIR. Montreal consequently acquired Evgenii Dadonov from Vegas in exchange from Weber's contract. “Our hope is that Carey is able to play and if that’s the case, great,” Canadiens GM Kent Hughes said. “If that were the case, then trading Shea’s contract may not have been that important to us, but we didn’t want to take that risk and, listen, we’re getting a hockey player back that we think can help our team."
Carey Price is facing an uncertain future because of his ailing knee, but he will prepare for next season as if he will be playing.
"I'm getting prepared to start my ramp-up and preparing for next season," Price said Friday. "I'm going to start preparing like I'm playing. I don't think I will actually have an idea of how that is going to look until later in the summer when I have taken all the necessary steps to get on the ice again." He mentioned that he had a platelet-rich plasma injection following the 2021-22 campaign. He was limited to just five appearances following offseason knee surgery as well as a stint in the NHL/NHLPA player assistance program. Price won the Bill Masterton Trophy on Friday, which is an award that goes annually to the NHL player who best exemplifies the qualities of perseverance, sportsmanship, and dedication to hockey.
Carey Price has won the Bill Masterton Memorial Trophy.
The award goes to the player who "best exemplifies the qualities of perseverance, sportsmanship, and dedication to hockey." Price underwent knee surgery in the offseason and voluntarily entered the NHL/NHLPA Player Assistance Program on Oct. 7, 2021. He made his return to the lineup on Apr. 17, 2022 and made five starts during the 2021-22 season for the Canadiens. Price went 1-4-0 with a 3.63 GAA and .878 save percentage. There are question marks about his status ahead of the 2022-23 campaign because of his knee. The other finalists for the Masterton this season were Zdeno Chara of the New York Islanders and Kevin Hayes of the Philadelphia Flyers.
DFS Last 5
Date | Opponent | Pts |
---|---|---|
Apr 29th | Panthers | 24.9 |
Apr 23rd | @Senators | -7 |
Apr 21st | Flyers | -1.4 |
Apr 19th | Wild | 12.6 |
Apr 15th | Islanders | 4.9 |